Chemical brain anatomy in schizophrenia. (Q40473365)

20 September 2017

1 reference

title

Chemical brain anatomy in schizophrenia. (English)

1 reference

20 September 2017

0 references

G Sedvall

1

1 reference

PubMed ID

7658878

20 September 2017

L Farde

series ordinal

2

1 reference

PubMed ID

7658878

20 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

20 September 2017

1 reference

20 September 2017

346

1 reference

20 September 2017

8977

1 reference

20 September 2017

743-749

1 reference

Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions.

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Serotonin release as a possible mechanism of reserpine action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Stereotyped activities produced by amphetamine in several animal species and man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Increased dopamine-receptor sensitivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Molecular diversity of the dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Dopamine D4 receptor subtypes and response to clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Dopamine receptor subtype imbalance in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Imaging of neurotransmitter receptors in the living human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Dopamine receptor gene expression in the human medial temporal lobe.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Glutamate in schizophrenics and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

CCK peptides and mRNA in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

Psychotomimesis mediated by kappa opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991508-7

7 January 2021

10.1016/S0140-6736(95)91508-7

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7658878